🇨🇳China·Startups·12 Nov 2026·via SCMP

    Former ByteDance AI scientist touts drug-discovery model that tops world leaders

    A new venture, Geodesic Intelligence, founded by a former ByteDance AI scientist, has released NovaAtom-Lite, an AI model for predicting biomolecular structures. Founder Quanquan Gu stated on social media that the model topped a third-party benchmark in several drug discovery tasks, with the firm claiming it outperforms existing state-of-the-art systems.

    Geodesic Intelligence's NovaAtom-Lite is an AI model designed to predict the structures and interactions of biomolecules. This function is fundamental to early-stage drug discovery, as accurately understanding how molecules interact is crucial for identifying and developing potential drug candidates.

    The model's founder, Quanquan Gu, reported on social media that NovaAtom-Lite achieved top performance in a third-party benchmark across various drug discovery tasks. Such a reported capability could help accelerate the initial phases of drug research by more efficiently pinpointing and analyzing promising biomolecular interactions, potentially speeding up the path to new treatments.

    However, the source does not detail the scope or methodology of this third-party benchmark, nor the specific drug discovery tasks involved. While the firm claims NovaAtom-Lite surpasses current state-of-the-art systems, the extent of its real-world impact or superiority remains to be independently validated and further detailed.

    Share this article

    Go deeper
    Original reporting by SCMPWe don't republish, read the full story â†’

    Related reading

    6 stories